Harpoon Therapeutics, Inc. (HARP) Tops Q2 EPS by 37c

Harpoon Therapeutics, Inc. (NASDAQ: HARP) reported Q2 EPS of $0.03, $0.37 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $20.22 million versus the consensus estimate of $5.14 million.

For earnings history and earnings-related data on Harpoon Therapeutics, Inc. (HARP) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Largo restructures $82.2M in debt, extending maturity to 2030
• Firm Capital Apartment REIT posts Q2 loss, plans name change